Additional file 1 of To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

  • Marieke Begemann (Contributor)
  • Ilse Thompson (Contributor)
  • Wim Veling (Contributor)
  • Shiral Gangadin (Contributor)
  • Chris Geraets (Contributor)
  • Erna Van ‘T Hag (Contributor)
  • Sanne Müller-Kuperus (Contributor)
  • Priscilla Oomen (Contributor)
  • Alban Voppel (Contributor)
  • Mark Gaag (Contributor)
  • Martijn Kikkert (Contributor)
  • Jim Os (Contributor)
  • H. Smit (Contributor)
  • Rikus Knegtering (Contributor)
  • Sybren Wiersma (Contributor)
  • Luyken Stouten (Contributor)
  • Harm Gijsman (Contributor)
  • Lex Wunderink (Contributor)
  • Anton Staring (Contributor)
  • Selene Veerman (Contributor)
  • Amrita Mahabir (Contributor)
  • Jörg Kurkamp (Contributor)
  • Gerdina Pijnenborg (Contributor)
  • Natalie Veen (Contributor)
  • Machteld Marcelis (Contributor)
  • Koen Grootens (Contributor)
  • Gunnar Faber (Contributor)
  • Nico Beveren (Contributor)
  • Agaath Been (Contributor)
  • Truus Brink (Contributor)
  • Maarten Bak (Contributor)
  • Therese Amelsvoort (Contributor)
  • Andrea Ruissen (Contributor)
  • Christine Blanke (Contributor)
  • Karin Groen (Contributor)
  • Lieuwe Haan (Contributor)
  • Iris Sommer (Contributor)

Dataset

Description

Additional file 1: Table S1. Tapering off schedules.
Date made available7 Feb 2020
PublisherUnknown Publisher

Cite this